| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/04/1999 | CA1340523C Assay for in vitro measurement of amino-telopeptides of type 1 collagen |
| 05/04/1999 | CA1340522C Fusion proteins containing neighbouring histidines for improved purification |
| 05/04/1999 | CA1340521C Hepatitis b virus antigen and a process for producing the same |
| 05/04/1999 | CA1340520C Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix |
| 04/30/1999 | CA2237419A1 An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 04/29/1999 | WO1999020797A1 HETEROLOGOUS POLYPEPTIDE PRODUCTION IN THE ABSENCE OF NONSENSE-MEDIATED mRNA DECAY FUNCTION |
| 04/29/1999 | WO1999020780A1 Positive-negative selection for homologous recombination |
| 04/29/1999 | WO1999020778A1 Gene delivery vectors and their uses |
| 04/29/1999 | WO1999020777A1 Bacterial resistance in grapevine |
| 04/29/1999 | WO1999020774A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 04/29/1999 | WO1999020766A2 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 04/29/1999 | WO1999020765A1 MUTEINS OF INTERLEUKIN 4 SHOWING LOW-AFFINITY AND SHORT-TERM INTERACTION WITH THE COMMON η CHAIN |
| 04/29/1999 | WO1999020764A1 Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 04/29/1999 | WO1999020762A1 Icam-6 materials and methods |
| 04/29/1999 | WO1999020761A2 Compositions and methods for identifying and testing therapeutics against hsv infection |
| 04/29/1999 | WO1999020760A2 Herg family potassium ion channel genes and protein |
| 04/29/1999 | WO1999020759A1 Chemokines with amino-terminal modifications |
| 04/29/1999 | WO1999020758A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | WO1999020757A2 Alpha-7 nicotinic receptor |
| 04/29/1999 | WO1999020756A2 Human toll homologues |
| 04/29/1999 | WO1999020755A2 Novel cytokine receptors |
| 04/29/1999 | WO1999020754A1 A ph sensitive potassium channel in spermatocytes |
| 04/29/1999 | WO1999020752A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF |
| 04/29/1999 | WO1999020751A1 Dna encoding a gababr2 polypeptide and uses thereof |
| 04/29/1999 | WO1999020749A1 Method to screen phage display libraries with different ligands |
| 04/29/1999 | WO1999020743A1 Cell lines useful for in vitro assay for identification of carcinogens |
| 04/29/1999 | WO1999020655A1 Method for purifying thrombin substrates and/or inhibitors or method for eliminating the same |
| 04/29/1999 | WO1999020654A2 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 04/29/1999 | WO1999020653A1 Low-toxicity human interferon-alpha analog |
| 04/29/1999 | WO1999020652A1 Feline granulocyte colony-stimulating factor |
| 04/29/1999 | WO1999020650A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS |
| 04/29/1999 | WO1999020645A1 Vesicular amino acid transporter composition and method |
| 04/29/1999 | WO1999020644A1 Secreted proteins and polynucleotides encoding them |
| 04/29/1999 | WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | WO1999020642A2 Unique genes associated with the activation of neutrophils by infectious agents |
| 04/29/1999 | WO1999020307A1 NOVEL pheS (BETA) |
| 04/29/1999 | WO1999020306A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/29/1999 | WO1999020304A1 Passive immunization against clostridium difficile disease |
| 04/29/1999 | WO1999020302A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | WO1999020295A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | WO1999020288A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 04/29/1999 | WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 04/29/1999 | WO1999020122A1 Increasing the digestibility of food proteins by thioredoxin reduction |
| 04/29/1999 | WO1999020121A2 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 04/29/1999 | WO1999020108A1 Human papillomavirus vectors for the episomal transduction of host cells and method of making same |
| 04/29/1999 | WO1999007740A3 Lipocalin homologs |
| 04/29/1999 | WO1999007735A3 Recombinant expression of insulin c-peptide |
| 04/29/1999 | WO1999006551A3 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 04/29/1999 | WO1999006550A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
| 04/29/1999 | WO1999006069A9 Herpes virus replication defective mutants |
| 04/29/1999 | WO1999006066A3 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 04/29/1999 | WO1999004825A9 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 04/29/1999 | WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders |
| 04/29/1999 | WO1999004636A9 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 04/29/1999 | WO1999003452A9 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/29/1999 | WO1999002690A9 Systemin |
| 04/29/1999 | WO1999001473A3 Anti-bacterial methods and materials |
| 04/29/1999 | WO1998051780B1 Method for increasing yields or recombinant proteins |
| 04/29/1999 | WO1998042296A9 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 04/29/1999 | WO1998041648A3 Target genes for allele-specific drugs |
| 04/29/1999 | DE19821843A1 Preparation of autologous human blood cytokine(s) |
| 04/29/1999 | CA2501585A1 Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 04/29/1999 | CA2315143A1 Method for refinement or method for elimination of thrombin substrate |
| 04/29/1999 | CA2308114A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | CA2307331A1 Passive immunization against clostridium difficile disease |
| 04/29/1999 | CA2307330A1 Jmy, a co-activator for p300/cbp, nucleic acid encoding jmy and uses thereof |
| 04/29/1999 | CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | CA2307062A1 A ph sensitive potassium channel in spermatocytes |
| 04/29/1999 | CA2307012A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | CA2306995A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/29/1999 | CA2306953A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | CA2306799A1 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |
| 04/29/1999 | CA2306796A1 Novel modified msp-1 nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |
| 04/29/1999 | CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | CA2306693A1 Cell lines useful for in vitro assay for identification of carcinogens |
| 04/29/1999 | CA2306629A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 04/29/1999 | CA2306457A1 Secreted proteins and polynucleotides encoding them |
| 04/29/1999 | CA2306454A1 Bacterial resistance in grapevine |
| 04/29/1999 | CA2306252A1 Gene delivery vectors and their uses |
| 04/29/1999 | CA2306251A1 Alpha-7 nicotinic receptor |
| 04/29/1999 | CA2305385A1 Human toll homologues |
| 04/29/1999 | CA2273193A1 Novel human .beta.2 integrin alpha subunit |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911413A2 Minimal adenovirus-based gene therapy vector |
| 04/28/1999 | EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911401A1 Muteins of interleukin 4 showing low-affinity and short-term interaction with the common gamma chain |
| 04/28/1999 | EP0911400A1 Antisense compounds to cd14 |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911398A2 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911397A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
| 04/28/1999 | EP0911396A2 Methods for generating polynucleotides having desired characteristics by iterative selective and recombination |
| 04/28/1999 | EP0911393A1 Novel peptide, process for the production of the same, and use of the same |
| 04/28/1999 | EP0911390A2 Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911343A2 Type IV collagen high molecular form, and production and diagnostic use thereof |
| 04/28/1999 | EP0911342A1 Novel protein and process for producing the same |
| 04/28/1999 | EP0911341A1 Adenine nucleotide translocator |